Representing a number of high profile pharmaceutical and biotechnology companies, including Boehringer Ingelheim and Roche, King & Wood Mallesons healthcare and life sciences practice is one of the PRC market’s most sought after. The practice is led by Jianwen Huang, who specialises in regulatory compliance advice for pharmaceutical drug, medical device, health food, and cosmetics producers in China. Mark Zhang, who advises on competition law matters in the healthcare and pharma space, is also key, as are investigations specialist Yuanyuan Zhu, the dispute resolution focussed Fan Yang and corporate compliance expert Ting Liu. Associate Lingbi Li, an expert on foreign and outbound investment matters, is a further key name. The firm is recommended for its understanding of the ‘commercial needs of clients’.
Testimonials
Collated independently by Legal 500 research team.
‘Mark Zhang's team of lawyers provides excellent legal services in the medical field. Its legal application is flexible and its risk considerations are comprehensive, but at the same time the lawyers take into account the commercial needs of clients.’
‘The response time is very fast, especially for urgent and independent issues that can require immediate advice.'
Key clients
- Boehringer Ingelheim
- Roche / Chugai